Medical University of South Carolina Frontiers in Preventive Cardiology and Cardiometabolic Health 2024
$40.00
This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!
Include: 28 videos, size: 10.6 GB
Medical University of South Carolina Frontiers in Preventive Cardiology and Cardiometabolic Health 2024
Include: 28 videos, size: 10.6 GB
Target Audience: cardiologists, endocrinologists, primary care physicians
Information:
Rapid developments in methods for cardiovascular (CV) disease risk evaluation and recent advances in pharmacological and procedural strategies for management of cardiometabolic risk factors have significantly improved our ability to identify and treat at-risk patients.
Join our internationally renowned faculty for updates on contemporary understanding of cardiovascular disease risk algorithms, polygenic risk scores, biomarkers and CV risk, preventive imaging, and female specific risk factors and learn how to incorporate strategies for personalization of risk assessment for each of your unique patients. Develop skills in recognizing the early, multi-system signs of cardiometabolic disease beyond the heart, including metabolic liver and renal diseases and consider newer pharmacological strategies for organ protection. Targeting obesity is now imperative, particularly in at-risk patients early in the cardiometabolic continuum.
Advance your skills in designing a comprehensive management strategy that includes lifestyle, as well as groundbreaking anti-obesity medications and surgical approaches to weight management. The landscape of lipid pharmacotherapy has never been more expansive and the most recent expert guidance on incorporation of these agents into clinical practice will be considered. Presentations of complex patient cases from the real-world will stimulate challenging discussions among participants and expert panelists. And just to keep you at the absolute peak of your scientific evidence game, join us for a session on the Top Trials of 2023-24 in preventive cardiology and cardiometabolic health that will impact your patient care!
LEARNING OBJECTIVES
At the completion of this conference, participants should be able to:
- Incorporate comprehensive cardiovascular risk assessment into routine clinical practice and personalize evaluation based on the patient’s unique risk profile.
- Formulate treatment strategies to target obesity early in the cardiometabolic risk continuum.
- Select pharmacotherapy for management of dyslipidemia and reduction of cardiovascular risk based on current scientific evidence and expert guidance.
- Intervene early for renal and hepatic protection in patients with cardiometabolic disease.
The Medical University of South Carolina (MUSC) Frontiers in Preventive Cardiology and Cardiometabolic Health 2024 conference is designed for a wide range of healthcare professionals interested in preventive cardiology and cardiometabolic health. The target audience includes:
- Cardiologists
- Endocrinologists
- Primary care physicians
- Nurse practitioners
- Physician assistants
- Pharmacists
- Allied health professionals
This conference focuses on the latest advancements in cardiovascular disease risk evaluation, pharmacological strategies, and comprehensive management of cardiometabolic risk factors.
Topics:
- A New Era in Renal Protection in Cardiometabolic Disease.mp4
- Bariatric Surgery Update.mp4
- Big Questions About Lipoprotein “Little” (a).mp4
- Changing the Paradigm The Top Recent Trials in Preventive Cardiology and Cardiometabolic Health.mp4
- Clear Outcomes – The First (and Only) Trial in Statin Intolerant Patients.mp4
- Complex Case Discussion Dyslipidemia Management.mp4
- Complex Case Discussion Familial Hypercholesterolemia.mp4
- Effects of Dietary Sodium on Systolic Blood Pressure in Middle-Aged Individuals A Randomized Order Cross-Over Trial.mp4
- Evolving Therapies in Dyslipidemia, ASCVD Risk Reduction Putting It All Together in High-Risk Patients.mp4
- Managing the Cardiometabolic Health of Two or More (!)- Hypertensive Disorders of Pregnancy.mp4
- MASH, MASLD, MetALD New Names, New Insights in Liver Disease.mp4
- Metabolic Syndrome Missed Windows of Opportunity.mp4
- Panel Discussion on Bariatric Surgery and Therapies for Obesity Treatment.mp4
- Panel Discussion on CV Risk Assessment, Management of Women with CV Risk, and PREVENT Calculator.mp4
- Panel Discussion on MASLD Management, SGLT2 inhibitors, Obesity and Sleep Apnea.mp4
- Panel Discussion on Top Recent Trials in Preventive Cardiology and Cardiometabolic Health.mp4
- Panel Discussion on Treatments of Type 2 Diabetes and Obesity.mp4
- Patients in Cardiometabolic Jeopardy Evolving Strategies for Cardiovascular Disease Risk Assessment.mp4
- Pictures Are Worth 1,000 Words- The Role of Imaging in CV Risk Assessment and Risk Management.mp4
- Refining Management of Women at Risk Female Specific Risk Factors.mp4
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes The SELECT Trial.mp4
- Targeting Triglyceride-rich Lipoproteins and Their Remnants.mp4
- The Most Important Voice of All Learning to Hear the Patient’s Perspective.mp4
- The Top Clinical Trials in Preventive Cardiology VERVE 101.mp4
- Weight Management for CVD and Heart Failure.mp4
- When Lifestyle Alone Misses the Mark Pharmacological Advances for Management of Obesity.mp4
- When You Just Can’t Seem to Sleep It Off- Cardiovascular Risk and Sleep Apnea.mp4
- Where Lie the Keys to Treatment of Type 2 Diabetes Mellitus Finding the Perfect Fit in Comprehensive Diabetes Treatment.mp4
Related products
Endocrine and Nutrition COURSES
Harvard Fifty Ninth Annual Update Obstetrics and Gynecology 2023
Endocrine and Nutrition COURSES
Endocrine and Nutrition COURSES
Endocrine and Nutrition COURSES
Endocrine and Nutrition COURSES
Endocrine and Nutrition COURSES
Endocrine and Nutrition COURSES
Endocrine and Nutrition COURSES